Status:
UNKNOWN
Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients Treated With Intravitreal Injections
Lead Sponsor:
Helse Stavanger HF
Collaborating Sponsors:
Tor Paaske Utheim
Vegard Asgeir Forsaa
Conditions:
Dry Eye
Eligibility:
All Genders
50-100 years
Brief Summary
To investigate prevalence of dry eye disease in Norwegian patients with age-related macular degeneration receiving intravitreal injections, as well as to reveal possible risk factors of DED in this po...
Detailed Description
Questionaires (OSDI, McMonnies) and clinical investigation using the Oculus 5 Keratograph for objective ocular surface evaluation. Tear fluid samples will be collected for later biochemical analysis.
Eligibility Criteria
Inclusion
- AMD diagnosis
- Treated with intravitreal injection agents
Exclusion
- Not able to cooperate
Key Trial Info
Start Date :
June 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04458012
Start Date
June 25 2020
End Date
June 1 2024
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stavanger University Hospital, Department of Ophthalmology
Stavanger, Norway, 4068